tirzepatide same as mounjaro FDA approves new version of diabetes drug to be sold for weight loss Tirzepatide (Mounjaro & Zepbound) for

As such, it is relevent to ensure that reproductive health is part of every conversation when this medicine in prescribed to any woman of childbearing age

Abstract Objective: Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss

Pharmacologically, signaling studies demonstrate that tirzepatide mimics the actions of native GIP at the GIP receptor but shows bias at the GLP-1 receptor to favor cAMP generation over -arrestin recruitment, coincident with a weaker ability to drive GLP-1 receptor internalization compared with GLP-1

The false designation of origin argument effectively weaponizes the FDAs regulatory definitions in civil court

Gradual escalation minimizes GI side effects such as nausea and vomiting, and is correlated with better long-term adherence

#GLP1 #MetabolicHealth #GutHealth #Microbiome #Longevity #Biohacking #resbiotic *This statement has not been evaluated by the Food and Drug Administration